You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

satralizumab

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Eye Disease Trial (Satralizumab, Placebo)

Not yet recruiting
  • Thyroid Eye Disease
  • Satralizumab
  • Placebo
  • (no location specified)
Oct 25, 2023

Thyroid Eye Disease Trial (Satralizumab, Placebo)

Not yet recruiting
  • Thyroid Eye Disease
  • Satralizumab
  • Placebo
  • (no location specified)
Aug 4, 2023

Aneurysmal Subarachnoid Hemorrhage, Delayed Cerebral Ischemia Trial in Gainesville (Satralizumab)

Not yet recruiting
  • Aneurysmal Subarachnoid Hemorrhage
  • Delayed Cerebral Ischemia
  • Satralizumab
  • Gainesville, Florida
    University of Florida (UF) Health Shands Hospital
Feb 13, 2023

Neuromyelitis Optica Spectrum Disorder, NMOSD Trial in Le Kremlin-bicêtre, Gdansk (Satralizumab)

Recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • NMOSD
  • Satralizumab
  • Le Kremlin-bicêtre, France
  • +1 more
Aug 17, 2022

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Trial in Germany, Italy, United States (Satralizumab,

Recruiting
  • Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
  • Satralizumab
  • Placebo
  • Washington, District of Columbia
  • +3 more
Aug 2, 2022

NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis Trial in Prague, Praha 5 (Satralizumab, Placebo)

Not yet recruiting
  • NMDAR Autoimmune Encephalitis
  • LGI1 Autoimmune Encephalitis
  • Satralizumab
  • Placebo
  • Prague, Czechia
  • +1 more
Aug 15, 2022

Neuromyelitis Optica (NMO), NMO Spectrum Disorder (NMOSD) Trial in Worldwide (Satralizumab, Placebo, Baseline Treatment)

Completed
Has Results
  • Neuromyelitis Optica (NMO)
  • NMO Spectrum Disorder (NMOSD)
  • Satralizumab
  • +2 more
  • Birmingham, Alabama
  • +38 more
Jan 24, 2022

Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (satralizumab, azathioprine (AZA), mycophenolate mofetil (MMF))

Active, not recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • satralizumab
  • +3 more
  • Birmingham, Alabama
  • +52 more
Mar 16, 2022

Neuromyelitis Optica (NMO), NMO Spectrum Disorder (NMOSD) Trial in Worldwide (Satralizumab, Placebo)

Completed
Has Results
  • Neuromyelitis Optica (NMO)
  • NMO Spectrum Disorder (NMOSD)
  • Satralizumab
  • Placebo
  • Aurora, Colorado
  • +57 more
Feb 11, 2022

Generalized Myasthenia Gravis Trial in Worldwide (Satralizumab, Placebo)

Recruiting
  • Generalized Myasthenia Gravis
  • Satralizumab
  • Placebo
  • Scottsdale, Arizona
  • +94 more
Aug 16, 2022